Lynx Biosciences
San Diego
About Lynx Biosciences
LynxBiosciencesis a clinical-stage biotechnology company focused on transforming the development of blood cancer therapies and delivering precise patient management by identifying the most promising therapeutic options. It is combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates in oncology and bringing personalized cancer treatments to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Private Equity
- Last round: Private Equity (Jan 2023)
- Website: lynx.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/lynx-biosciences-196111 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.